Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema.

The importance of laboratory testing in the diagnosis of hereditary angioedema (HAE) has increased with the advent of new treatment options in recent years. It has been 50 years since HAE was linked to a decrease of C1INH (the inhibitor of complement enzyme, C1 esterase), a link that provided for the first laboratory test available for this disorder. HAE is subdivided into types that can be differentiated only by laboratory testing. The Type I form is characterized by low levels and function of C1INH in the circulation. The Type II form is characterized by normal levels of C1INH, but low function. Sample collection and handling is critical for the functional assays. The serum samples for the functional analysis must be collected, separated, and frozen at less than -60°C within 2 hours of the blood draw. Additionally some suspected Type II patients may benefit from looking closely at what method is used for the functional testing. The acquired forms of angioedema (AAE) can benefit from the same clinical testing, because most are ultimately due to decreased C1INH. Measurement of C1q levels and testing for anti-C1INH autoantibodies can help differentiate AAE from HAE. Diagnostic testing for the third hereditary form, alternately called estrogen-dependent HAE, HAE with Normal C1INH or HAE Type III, still presents challenges, and definitive testing may have to wait until there is a more complete understanding of this mixed group of patients. The next steps will include genetic analysis of C1INH and other proteins involved in HAE.

[1]  D. Khan.  Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis. , 2011, Allergy and asthma proceedings.

[2]  Pedro Mejia,et al.  C1 inhibitor, a multi-functional serine protease inhibitor , 2010, Thrombosis and Haemostasis.

[3]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[4]  M. Cicardi,et al.  The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. , 2010, Current molecular medicine.

[5]  M. Cicardi,et al.  Angioedema due to C1 inhibitor deficiency in 2010 , 2010, Internal and emergency medicine.

[6]  B. Zuraw,et al.  Pathogenesis and laboratory diagnosis of hereditary angioedema. , 2009, Allergy and asthma proceedings.

[7]  K. Bork,et al.  Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. , 2009, The Journal of allergy and clinical immunology.

[8]  A. Sheffer,et al.  The spectrum of chronic angioedema. , 2009, Allergy and asthma proceedings.

[9]  H. Joller-jemelka,et al.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. , 2008, Journal of immunological methods.

[10]  B. Zuraw.  Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  K. Bork,et al.  Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. , 2007, The American journal of medicine.

[12]  M. Mohammadi,et al.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema , 2007, Clinical and experimental immunology.

[13]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[14]  A. Davis.  C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.

[15]  J. Curd,et al.  The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. , 1986, The Journal of allergy and clinical immunology.

[16]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[17]  E. Becker,et al.  Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein , 1962 .

[18]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .